I

Inovio Pharmaceuticals
D

INO

2.23000
USD
0.02
(0.91%)
Market Closed
Volume
45,004
EPS
-2
Div Yield
-
P/E
-1
Market Cap
80,502,980
Related Instruments
    A
    AMRN
    -0.00130
    (-0.22%)
    0.58930 USD
    A
    ARWR
    -1.040
    (-4.97%)
    19.900 USD
    A
    AXSM
    8.550
    (6.62%)
    137.720 USD
    C
    CRSP
    -2.620
    (-5.19%)
    47.840 USD
    E
    EDIT
    -0.14000
    (-6.80%)
    1.92000 USD
    I
    INO
    0.02000
    (0.91%)
    2.23000 USD
    S
    SRPT
    -2.010
    (-1.86%)
    106.280 USD
    V
    VCEL
    -2.230
    (-4.11%)
    52.060 USD
    V
    VKTX
    2.480
    (7.85%)
    34.090 USD
    More
News

Title: Inovio Pharmaceuticals

Sector: Healthcare
Industry: Biotechnology
Inovio Pharmaceuticals Inc is a United States-based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.